| Preface |
|
iii | |
| Contributors |
|
xi | |
|
Human Immunodeficiency Virus Prevention: Applying the Lessons Learned |
|
|
1 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intervention Strategies: Levels of Interventions |
|
|
4 | (9) |
|
|
|
13 | (3) |
|
What Can We Recommend Now? |
|
|
16 | (1) |
|
|
|
17 | (6) |
|
|
|
17 | (6) |
|
Novel Strategies Toward the Development of an Effective Vaccine to Prevent Human Immunodeficiency Virus Infection or Acquired Immunodeficiency Virus |
|
|
23 | (40) |
|
|
|
|
|
|
|
|
|
|
|
How AIDS Vaccine Strategies Have Evolved from Sterilizing Immunity to the Control of Infection |
|
|
25 | (4) |
|
Live Attenuated Vaccines: Concepts to Learn |
|
|
29 | (1) |
|
|
|
30 | (13) |
|
Conclusions and Perspectives |
|
|
43 | (20) |
|
|
|
46 | (17) |
|
Pediatric Human Immunodeficiency Virus Type 1 Infection: Updates on Prevention and Management |
|
|
63 | (22) |
|
|
|
|
|
|
|
|
|
|
|
|
|
65 | (1) |
|
Maternal and Obstetrical Factors Associated with Perinatal HIV-1 Transmission |
|
|
66 | (9) |
|
Antiretroviral Therapy for HIV-1-Infected Children |
|
|
75 | (2) |
|
|
|
77 | (8) |
|
|
|
77 | (8) |
|
Risk of Human Immunodeficiency Virus Infection in Health Care Workers |
|
|
85 | (16) |
|
|
|
|
|
|
|
|
87 | (1) |
|
Anecdotal Case Reports of Occupational HIV Infection |
|
|
88 | (3) |
|
Prospective Cohort Studies |
|
|
91 | (1) |
|
|
|
92 | (2) |
|
Management of Occupational Exposure |
|
|
94 | (2) |
|
HIV-Infected Health Care Workers: Risks to Patients |
|
|
96 | (1) |
|
|
|
97 | (4) |
|
|
|
98 | (3) |
|
Can Immune Responses to Human Immunodeficiency Virus Be Preserved, Enhanced, or Restored? |
|
|
101 | (14) |
|
|
|
|
|
|
|
|
103 | (1) |
|
Components of Protective Immunity in HIV Infection |
|
|
104 | (2) |
|
Why Does the Immune System Fail to Control HIV? |
|
|
106 | (1) |
|
Effects of Highly Active Antiretroviral Therapy (HAART) on HIV-Specific Immune Responses |
|
|
106 | (1) |
|
Rebuilding the Immune System in Chronic HIV Infection |
|
|
107 | (1) |
|
Critical Need for Immunotherapy plus HAART in Augmenting Immunity to HIV |
|
|
108 | (1) |
|
Approaches to Immune Enhancement in HIV Infection |
|
|
109 | (1) |
|
Conclusions and Future Directions |
|
|
110 | (5) |
|
|
|
111 | (4) |
|
Reconstitution of Immunity Against Opportunistic Infections in the Era of Potent Antiretroviral Therapy |
|
|
115 | (24) |
|
|
|
|
|
|
|
|
117 | (1) |
|
|
|
118 | (5) |
|
|
|
123 | (3) |
|
|
|
126 | (3) |
|
|
|
129 | (1) |
|
|
|
130 | (1) |
|
|
|
130 | (9) |
|
|
|
131 | (8) |
|
Salvage Therapy for Patients Failing their Current Antiretroviral Regimen |
|
|
139 | (54) |
|
|
|
|
|
|
|
|
141 | (3) |
|
Defining Virologic Failure |
|
|
144 | (1) |
|
|
|
145 | (1) |
|
|
|
146 | (4) |
|
Salvage Therapy in Patients Failing PI-Containing Regimens: Clinical Trial Results |
|
|
150 | (9) |
|
Role of Intensification Strategies |
|
|
159 | (2) |
|
Predictors of Treatment Response |
|
|
161 | (8) |
|
Role of Genotypic and Phenotypic Resistance Assays in Devising Salvage Therapy |
|
|
169 | (7) |
|
Structured Treatment Interruptions |
|
|
176 | (1) |
|
Multidrug Rescue Regimens |
|
|
177 | (2) |
|
|
|
179 | (14) |
|
|
|
180 | (13) |
|
Drug Interactions of Antiretroviral Agents |
|
|
193 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
195 | (2) |
|
Interpretation of Drug Concentrations |
|
|
197 | (1) |
|
|
|
197 | (1) |
|
|
|
198 | (2) |
|
Nucleoside Reverse Transcriptase Inhibitors |
|
|
200 | (4) |
|
|
|
204 | (5) |
|
NNRTI and PI Combinations |
|
|
209 | (5) |
|
Management of Non-ARV Drug Interactions |
|
|
214 | (6) |
|
|
|
220 | (9) |
|
|
|
221 | (8) |
|
Rationale for Immune-Based Therapies for Human Immunodeficiency Virus Type 1 Infection |
|
|
229 | (34) |
|
|
|
|
|
|
|
|
|
|
|
Rationale for Immune-Based Therapies |
|
|
231 | (2) |
|
|
|
233 | (4) |
|
Cytokines and Growth Factors |
|
|
237 | (5) |
|
Enhancement of HIV-1 Specific Immune Responses |
|
|
242 | (7) |
|
|
|
249 | (14) |
|
|
|
250 | (13) |
|
Human Immunodeficiency Virus and Hepatitis B and C Coinfection: Pathogenic Interactions, Natural History, and Therapy |
|
|
263 | (44) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
265 | (1) |
|
|
|
266 | (4) |
|
|
|
270 | (16) |
|
|
|
286 | (21) |
|
|
|
286 | (21) |
| Index |
|
307 | |
Shopping Cart
